Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
AffaMed Therapeutics
company
About
AffaMed Therapeutics is a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products.
- New City,New York,United States
- 101 - 250
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $170M
- Industries
- Biotechnology
- Founded date
- Jan 1, 2019
- Number Of Employee
- 101 - 250
- Operating Status
- Active
AffaMed Therapeutics is a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$170M
AffaMed Therapeutics has raised a total of
$170M
in funding over 2 rounds. Their latest funding was raised on
Mar 30, 2021 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 30, 2021 | Series B | $170M | 6 |
Lake Bleu Capital
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
6
AffaMed Therapeutics is funded by 6 investors.
Lake Bleu Capital
and Superstring Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Lake Bleu Capital
|
Yes | Series B |
|
|
— | Series B |
CBC Investment Group
|
— | Series B |
Fountainhead Investment Partners
|
— | Series B |
Orion Capital Group, Inc.
|
— | Series B |
Partners Investment
|
— | Series B |
Employee Profiles
Number of Employee Profiles
4
AffaMed Therapeutics has 4 current employee profiles, including
Executive Michael Keyoung
Acquisition
AffaMed Therapeutics has acquired 1 organizations. Their most recent acquisition was EverInsight Therapeutics on Oct 14, 2020. They acquired EverInsight Therapeutics for 0.
|
Date
Company Name
|
Industry | Acquisition Type | Price | |
|---|---|---|---|---|
|
Oct 14, 2020
|
Biotechnology | merge | — | Detail |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
